- Published on
Infectious Disease and Microbiology – Brain Abscess
Brain abscess is a focal collection of purulent material within the brain parenchyma caused by bacterial, fungal, or protozoal infection. It may present as a well-formed abscess with a defined capsule or as an early inflammatory stage known as cerebritis. This is a rare condition, identified in 0.2–1.3% of large autopsy series and approximately 1 in 10,000 hospital admissions. About 25% of cases occur in children, and the median age at diagnosis is 30–45 years.
Risk factors include sinusitis, otitis media, poor dental hygiene, infective endocarditis, bacteremia from indwelling central lines or intravenous drug use, Osler–Weber–Rendu disease, preexisting brain injury, immunodeficiency, cyanotic congenital heart disease, and intrapulmonary shunting due to arteriovenous malformations. Preventive strategies involve prompt treatment of sinus and ear infections and maintaining good dental hygiene, particularly management of upper molar abscesses.
Infection reaches the brain through direct extension from adjacent structures (sinuses, middle ear, mastoid, orbit, teeth, meninges), following trauma or neurosurgery, or via hematogenous spread. The causative organisms often reflect the source. Otogenic, sinus, and odontogenic infections commonly involve mixed flora including anaerobes, microaerophilic and viridans streptococci, Streptococcus milleri, Haemophilus species, Fusobacterium, Prevotella, Enterobacteriaceae, and Pseudomonas. Post-traumatic or postoperative infections frequently involve Staphylococcus aureus, Pseudomonas, other gram-negative bacilli, and Propionibacterium. Hematogenous spread may involve S. aureus, streptococci, Salmonella, Listeria, Klebsiella pneumoniae, Escherichia coli, Proteus, Pseudomonas, Bacteroides species, Actinomyces, and fungi. In immunocompromised hosts, pathogens include Toxoplasma gondii, Listeria, Rhodococcus equi, Nocardia asteroides, Aspergillus, Cryptococcus neoformans, Coccidioides immitis, Candida, Zygomycetes, Cladosporium, and Curvularia. In immigrants from endemic areas, parasitic causes such as Taenia solium, Entamoeba histolytica, Schistosoma japonicum, and Paragonimus species should be considered.
Clinical manifestations are often subtle and nonspecific. Headache of less than two weeks’ duration occurs in approximately 75% of patients. Other symptoms include neck stiffness (25%), mental status changes, nausea, vomiting, low-grade fever (45–50%), focal neurological deficits (50%), and seizures (25%), which may prompt initial neuroimaging. Signs of increased intracranial pressure such as papilledema and third or sixth cranial nerve palsies suggest significant cerebral edema. Presentation varies depending on abscess location, pathogen, and underlying disease.
Laboratory findings may show leukocytosis in 60–70% of patients and elevated ESR in up to 90%. Lumbar puncture is generally contraindicated in patients with focal neurological signs due to risk of herniation. Blood cultures may be positive. Definitive microbiological diagnosis is achieved through stereotactic aspiration with Gram stain, culture, special stains, and increasingly 16S ribosomal RNA sequencing. Serologic testing may assist in suspected toxoplasmosis or neurocysticercosis.
Neuroimaging with CT or MRI is essential. Gadolinium-enhanced MRI provides superior visualization, especially in the brainstem, and diffusion-weighted imaging helps distinguish abscesses from neoplastic lesions. Ring-enhancing lesions may persist for several months despite adequate therapy. Serial imaging is necessary to monitor response to treatment.
Stereotactic aspiration is the procedure of choice for abscesses larger than 2.5 cm and that are surgically accessible. Craniotomy with aspiration may be required when vascular structures must be directly visualized. Differential diagnosis includes epidural or subdural empyema, septic dural sinus thrombosis, mycotic aneurysms, septic emboli with infarction, necrotizing encephalitis, primary or metastatic brain tumors, pyogenic meningitis, hematoma, and radiation necrosis.
Management requires prompt initiation of empiric intravenous antibiotics after appropriate cultures are obtained. For abscesses arising from oral, sinus, or otogenic sources, cefotaxime or ceftriaxone combined with metronidazole is recommended. Alternatively, penicillin G plus metronidazole may be used for oral sources. For suspected hematogenous spread, vancomycin combined with metronidazole and a third-generation cephalosporin is advised. Postsurgical infections should be treated with vancomycin plus ceftazidime or cefepime. If methicillin-sensitive S. aureus is identified, vancomycin should be replaced with nafcillin or oxacillin for improved CNS penetration. Therapy typically continues for 6–8 weeks or longer, guided by clinical and radiographic response. Corticosteroids may be used in cases of significant mass effect and depressed mental status. Surgical intervention is both diagnostic and therapeutic, relieving intracranial pressure and providing material for microbiologic diagnosis.
Complications include cerebral herniation (15–20%), persistent neurological deficits such as hemiparesis (up to 50%), epilepsy (fewer than 50%), and significant morbidity. Mortality is strongly influenced by neurological status at presentation. Long-term follow-up with serial CT or MRI scans for at least one year after completion of antibiotics is recommended to monitor for recurrence or residual disease.
Brain abscess is a focal collection of purulent material within the brain parenchyma caused by bacterial, fungal, or protozoal infection. It may present as a well-formed abscess with a defined capsule or as an early inflammatory stage known as cerebritis. This is a rare condition, identified in 0.2–1.3% of large autopsy series and approximately 1 in 10,000 hospital admissions. About 25% of cases occur in children, and the median age at diagnosis is 30–45 years.
Risk factors include sinusitis, otitis media, poor dental hygiene, infective endocarditis, bacteremia from indwelling central lines or intravenous drug use, Osler–Weber–Rendu disease, preexisting brain injury, immunodeficiency, cyanotic congenital heart disease, and intrapulmonary shunting due to arteriovenous malformations. Preventive strategies involve prompt treatment of sinus and ear infections and maintaining good dental hygiene, particularly management of upper molar abscesses.
Infection reaches the brain through direct extension from adjacent structures (sinuses, middle ear, mastoid, orbit, teeth, meninges), following trauma or neurosurgery, or via hematogenous spread. The causative organisms often reflect the source. Otogenic, sinus, and odontogenic infections commonly involve mixed flora including anaerobes, microaerophilic and viridans streptococci, Streptococcus milleri, Haemophilus species, Fusobacterium, Prevotella, Enterobacteriaceae, and Pseudomonas. Post-traumatic or postoperative infections frequently involve Staphylococcus aureus, Pseudomonas, other gram-negative bacilli, and Propionibacterium. Hematogenous spread may involve S. aureus, streptococci, Salmonella, Listeria, Klebsiella pneumoniae, Escherichia coli, Proteus, Pseudomonas, Bacteroides species, Actinomyces, and fungi. In immunocompromised hosts, pathogens include Toxoplasma gondii, Listeria, Rhodococcus equi, Nocardia asteroides, Aspergillus, Cryptococcus neoformans, Coccidioides immitis, Candida, Zygomycetes, Cladosporium, and Curvularia. In immigrants from endemic areas, parasitic causes such as Taenia solium, Entamoeba histolytica, Schistosoma japonicum, and Paragonimus species should be considered.
Clinical manifestations are often subtle and nonspecific. Headache of less than two weeks’ duration occurs in approximately 75% of patients. Other symptoms include neck stiffness (25%), mental status changes, nausea, vomiting, low-grade fever (45–50%), focal neurological deficits (50%), and seizures (25%), which may prompt initial neuroimaging. Signs of increased intracranial pressure such as papilledema and third or sixth cranial nerve palsies suggest significant cerebral edema. Presentation varies depending on abscess location, pathogen, and underlying disease.
Laboratory findings may show leukocytosis in 60–70% of patients and elevated ESR in up to 90%. Lumbar puncture is generally contraindicated in patients with focal neurological signs due to risk of herniation. Blood cultures may be positive. Definitive microbiological diagnosis is achieved through stereotactic aspiration with Gram stain, culture, special stains, and increasingly 16S ribosomal RNA sequencing. Serologic testing may assist in suspected toxoplasmosis or neurocysticercosis.
Neuroimaging with CT or MRI is essential. Gadolinium-enhanced MRI provides superior visualization, especially in the brainstem, and diffusion-weighted imaging helps distinguish abscesses from neoplastic lesions. Ring-enhancing lesions may persist for several months despite adequate therapy. Serial imaging is necessary to monitor response to treatment.
Stereotactic aspiration is the procedure of choice for abscesses larger than 2.5 cm and that are surgically accessible. Craniotomy with aspiration may be required when vascular structures must be directly visualized. Differential diagnosis includes epidural or subdural empyema, septic dural sinus thrombosis, mycotic aneurysms, septic emboli with infarction, necrotizing encephalitis, primary or metastatic brain tumors, pyogenic meningitis, hematoma, and radiation necrosis.
Management requires prompt initiation of empiric intravenous antibiotics after appropriate cultures are obtained. For abscesses arising from oral, sinus, or otogenic sources, cefotaxime or ceftriaxone combined with metronidazole is recommended. Alternatively, penicillin G plus metronidazole may be used for oral sources. For suspected hematogenous spread, vancomycin combined with metronidazole and a third-generation cephalosporin is advised. Postsurgical infections should be treated with vancomycin plus ceftazidime or cefepime. If methicillin-sensitive S. aureus is identified, vancomycin should be replaced with nafcillin or oxacillin for improved CNS penetration. Therapy typically continues for 6–8 weeks or longer, guided by clinical and radiographic response. Corticosteroids may be used in cases of significant mass effect and depressed mental status. Surgical intervention is both diagnostic and therapeutic, relieving intracranial pressure and providing material for microbiologic diagnosis.
Complications include cerebral herniation (15–20%), persistent neurological deficits such as hemiparesis (up to 50%), epilepsy (fewer than 50%), and significant morbidity. Mortality is strongly influenced by neurological status at presentation. Long-term follow-up with serial CT or MRI scans for at least one year after completion of antibiotics is recommended to monitor for recurrence or residual disease.
0 Comments
